Effect of Secukinumab Dose Escalation on MRI-Detected Inflammation and Structural Damage in Axial Spondyloarthritis: A Clinical, Investigator-Initiated, Treat-to-Target Study (TRACE) RMD Open 12: e006774 (2026)
https://pubmed.ncbi.nlm.nih.gov/42035189/

Structural damage assessment in the spine of patients with axial spondyloarthritis – results from an international OMERACT multi-reader exercise using MRI-based synthetic CT (2026)
https://pubmed.ncbi.nlm.nih.gov/42308963/

Effect of apremilast on whole-body magnetic resonance imaging of peripheral and axial inflammation in patients with psoriatic arthritis (2026)
https://pubmed.ncbi.nlm.nih.gov/42191498/

Clinical and MRI remission in axial spondyloarthritis: One-year outcomes and predictors from the TRACE treat-to-target study with secukinumab (2026)
https://pubmed.ncbi.nlm.nih.gov/42035189/

Whole Body-MRI identifies widespread inflammation in peripheral joints, and axial involvement in a third of patients with early, treatment-naïve psoriatic arthritis: Data from the GOLMePsA clinical trial (2026)
https://pubmed.ncbi.nlm.nih.gov/42308540/

Discrepancies between routine sacroiliac joint MRI reporting and current expert recommendations in patients with spondyloarthritis; RMD Open 11(4):e006316. doi: 10.1136/rmdopen-2025-006316; 2025 (2025)
https://pmc.ncbi.nlm.nih.gov/articles/PMC12718560/

Sacroiliac joint involvement in psoriatic arthritis – MRI, radiographic and clinical findings in 581 European routine care patients (2025)
https://pubmed.ncbi.nlm.nih.gov/41023760/

How to Identify and Monitor Axial and Peripheral Psoriatic Arthritis by Magnetic Resonance Imaging (2025)
https://pubmed.ncbi.nlm.nih.gov/40763945/

Promising imaging methods for assessment of structural progression in axial spondyloarthritis (2025)
https://pubmed.ncbi.nlm.nih.gov/41093649/

Musculoskeletal symptoms and clinical findings in bio-naïve patients with inflammatory bowel disease prior to biological treatment initiation– a prospective cohort study (2025)
https://pubmed.ncbi.nlm.nih.gov/40232572/

Musculoskeletal symptoms and clinical findings in bio-naïve patients with inflammatory bowel disease prior to biological treatment initiation– a prospective cohort study (2025)
https://pubmed.ncbi.nlm.nih.gov/40232572/

Challenge of missing data in observational studies – Investigating cross-sectional imputation methods for assessing disease activity in axial spondyloarthritis (2025)
https://pubmed.ncbi.nlm.nih.gov/39979039/

The Impact of Ixekizumab Treatment on MRI Sacroiliac Joint Structural Lesions in Patients with Radiographic Axial Spondyloarthritis: 52-Week Results from a Randomised Placebo-Controlled Trial with an Active Comparator. (2025)
https://pubmed.ncbi.nlm.nih.gov/39983751/

Effect of apremilast on hand and whole-body magnetic resonance imaging evidence of inflammation in patients with psoriatic arthritis: a phase 4, multicenter, single-arm, open-label study (2025)
https://pubmed.ncbi.nlm.nih.gov/39488216/

Spine and sacroiliac joint involvement in patients newly diagnosed with inflammatory bowel disease – clinical and magnetic resonance imaging findings from a population-based cohort study (2025)
https://pubmed.ncbi.nlm.nih.gov/39162769/

Biological material for biomarker research in spondyloarthritis: Mapping the availability in European rheumatology registries (2025)
https://pubmed.ncbi.nlm.nih.gov/39078721/

Construct validity and responsiveness of ASAS Health Index assessed in two longitudinal studies of tumour necrosis factor alpha inhibitor initiation and dose reduction in patients with axial spondyloarthritis (2024)
https://pubmed.ncbi.nlm.nih.gov/39794273/

Clinical information on imaging referrals for suspected or known axial spondyloarthritis: Recommendations from the Assessment of Spondyloarthritis International Society (ASAS) (2024)
https://pubmed.ncbi.nlm.nih.gov/39317418/

Impact of patient characteristics on ASDAS disease activity state cut-offs in axial spondyloarthritis: results from nine European rheumatology registries (2024)
https://pubmed.ncbi.nlm.nih.gov/39489531/

Effect of secukinumab versus adalimumab biosimilar on radiographic progression in patients with radiographic axial spondyloarthritis: Results from a head-to-head randomized phase IIIb study (2024)
https://pubmed.ncbi.nlm.nih.gov/38556921/

Enthesitis in a European registry-based cohort of patients with psoriatic arthritis treated with tumour necrosis factor inhibitors: clinical burden, patient-reported outcomes, and treatment response (2024)
https://pubmed.ncbi.nlm.nih.gov/38771017/

Comparing DAPSA, DAPSA28 and DAS28-CRP in patients with psoriatic arthritis initiating a first TNF-inhibitor across nine European countries (2024)
https://pubmed.ncbi.nlm.nih.gov/38926900/

Detection of structural lesions of the sacroiliac joints in patients with spondyloarthritis: A comparison of T1-weighted 3D spoiled gradient echo MRI and MRI-based synthetic CT versus T1-weighted turbo spin echo MRI. (2024)
https://pubmed.ncbi.nlm.nih.gov/38592521/

MRI-based synthetic computed tomography: A new method for structural damage assessment in the spine in patients with axial spondyloarthritis – a comparison with low-dose CT and radiography (2024)
https://pubmed.ncbi.nlm.nih.gov/38490729/

The OMERACT whole-body MRI scoring system for inflammation in peripheral joints and entheses (WIPE) in spondyloarthritis – reference image atlas for the knee region (2024)
https://pubmed.ncbi.nlm.nih.gov/38325053/

Hip and pelvis region MRI reference image atlas for scoring inflammation in peripheral joints and entheses according to the OMERACT-MRI WIPE scoring system in patients with spondyloarthritis (2024)
https://pubmed.ncbi.nlm.nih.gov/38325055/

Peripheral joint and enthesis involvement in newly diagnosed patients with inflammatory bowel disease (IBD): symptoms, clinical and ultrasonographic findings – A population-based cohort study (2024)
https://pubmed.ncbi.nlm.nih.gov/38366120/

Reporting sacroiliac joint imaging examinations in patients with known or suspected axial Spondyloarthritis: Recommendations from the Assessment of Spondyloarthritis International Society (2024)
https://pubmed.ncbi.nlm.nih.gov/38860891/

Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF-inhibitor: results from 13 European registries (2024)
https://pubmed.ncbi.nlm.nih.gov/37314967/

Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care (2024)
https://pubmed.ncbi.nlm.nih.gov/38224992/

Occurrence and prediction of flare after tapering of TNF inhibitors in patients with axial spondyloarthritis (2023)
https://pubmed.ncbi.nlm.nih.gov/37839816/

MRI lesions of the spine in patients with axial spondyloarthritis: an update of lesion definitions and validation by the ASAS MRI working group (2022)
https://pubmed.ncbi.nlm.nih.gov/35609977/

Morphological characteristics of sacroiliac joint MRI lesions in axial spondyloarthritis and control subjects (2022)
https://pubmed.ncbi.nlm.nih.gov/34097000/

Extracellular matrix protein turnover markers are associated with axial spondyloarthritis-a comparison with postpartum women and other non-axial spondyloarthritis controls with or without back pain (2022)
https://pubmed.ncbi.nlm.nih.gov/35739562/

Enthesitis in patients with psoriatic arthritis and axial spondyloarthritis – data from the Danish nationwide DANBIO registry (2022)
https://pubmed.ncbi.nlm.nih.gov/35027245/

Anatomic Distribution of Sacroiliac Joint Lesions on Magnetic Resonance Imaging in Patients With Axial Spondyloarthritis and Control Subjects: A Prospective Cross-Sectional Study, Including Postpartum Women, Patients With Disc Herniation, Cleaning Staff, Runners, and Healthy Individuals (2021)
https://pubmed.ncbi.nlm.nih.gov/33002333/

Data-driven definitions for active and structural MRI lesions in the sacroiliac joint in spondyloarthritis and their predictive utility (2021)
https://pubmed.ncbi.nlm.nih.gov/33523107/

Arthritis and enthesitis in the hip and pelvis region in spondyloarthritis – OMERACT validation of two whole-body MRI methods (2021)
https://pubmed.ncbi.nlm.nih.gov/34140185/

Development and Validation of 3 Preliminary MRI Sacroiliac Joint Composite Structural Damage Scores in a 5-year Longitudinal Axial Spondyloarthritis Study (2021)
https://pubmed.ncbi.nlm.nih.gov/33858979/

The Value of Magnetic Resonance Imaging for Assessing Disease Extent and Prediction of Relapse in Early Peripheral Spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/33982902/

Imaging in psoriatic arthritis: Status and recent advances (2021)
https://pubmed.ncbi.nlm.nih.gov/34016527/

Whole-body Magnetic Resonance Imaging in Psoriatic Arthritis, Rheumatoid Arthritis, and Healthy Controls: Interscan, Intrareader, and Interreader Agreement and Distribution of Lesions (2021)
https://pubmed.ncbi.nlm.nih.gov/32541078/

Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial (2020)
https://pubmed.ncbi.nlm.nih.gov/31813637/

Whole-body Magnetic Resonance Imaging Inflammation in Peripheral Joints and Entheses in Axial Spondyloarthritis: Distribution and Changes during Adalimumab Treatment (2020)
https://pubmed.ncbi.nlm.nih.gov/30936290/

Test-retest repeatability of the apparent diffusion coefficient in sacroiliac joint MRI in patients with axial spondyloarthritis and healthy individuals (2020)
https://pubmed.ncbi.nlm.nih.gov/32206343/

Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration (2020)
https://pubmed.ncbi.nlm.nih.gov/32950963/

The utility of magnetic resonance imaging lesion combinations in the sacroiliac joints for diagnosing patients with axial spondyloarthritis. A prospective study of 204 participants including post-partum women, patients with disc herniation, cleaning staff, runners and healthy persons (2020)
https://pubmed.ncbi.nlm.nih.gov/32240310/

MRI of the sacroiliac joints: what is and what is not sacroiliitis? (2020)
https://pubmed.ncbi.nlm.nih.gov/32453038/

Scoring magnetic resonance imaging (MRI) inflammation and structural lesions in sacroiliac joints of patients with axial spondyloarthritis: assessment of all MRI slices of the cartilaginous compartment versus standardized six or five slices (2020)
https://pubmed.ncbi.nlm.nih.gov/31847676/

Atlas of the OMERACT Heel Enthesitis MRI Scoring System (HEMRIS) (2020)
https://pubmed.ncbi.nlm.nih.gov/32568094/

Efficacy and safety of cannabidiol followed by an open label add-on of tetrahydrocannabinol for the treatment of chronic pain in patients with rheumatoid arthritis or ankylosing spondylitis: protocol for a multicentre, randomised, placebo-controlled study (2019)
https://pubmed.ncbi.nlm.nih.gov/31167870/

The need for comparative data in spondyloarthritis (2019)
https://pubmed.ncbi.nlm.nih.gov/30670074/

Extremely poor patient-reported outcomes are associated with lack of clinical response and decreased retention rate of tumour necrosis factor inhibitor treatment in patients with axial spondyloarthritis (2019)
https://pubmed.ncbi.nlm.nih.gov/30102111/

Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration (2019)
https://pubmed.ncbi.nlm.nih.gov/31431486/

Canada-Denmark MRI scoring system of the spine in patients with axial spondyloarthritis: updated definitions, scoring rules and inter-reader reliability in a multiple reader setting (2019)
https://pubmed.ncbi.nlm.nih.gov/31673422/

Inflammatory and structural changes in vertebral bodies and posterior elements of the spine in axial spondyloarthritis: construct validity, responsiveness and discriminatory ability of the anatomy-based CANDEN scoring system in a randomised placebo-controlled trial (2018)
https://pubmed.ncbi.nlm.nih.gov/29556419/